National Health Investors (NYSE:NHI) Upgraded by StockNews.com to “Buy”

StockNews.com upgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a buy rating in a research note released on Monday.

A number of other analysts have also recently issued reports on NHI. BMO Capital Markets raised National Health Investors from a market perform rating to an outperform rating and set a $67.00 price objective for the company in a research report on Tuesday, March 12th. Stifel Nicolaus reaffirmed a hold rating and issued a $55.00 price objective on shares of National Health Investors in a research note on Tuesday, November 28th. Deutsche Bank Aktiengesellschaft assumed coverage on National Health Investors in a research report on Tuesday, January 30th. They issued a buy rating and a $69.00 price target for the company. Wedbush raised their price objective on National Health Investors from $64.00 to $66.00 and gave the company an outperform rating in a research note on Monday, March 18th. Finally, Wells Fargo & Company raised shares of National Health Investors from an equal weight rating to an overweight rating and lifted their price target for the company from $55.00 to $63.00 in a research report on Monday, February 26th. Four analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of Moderate Buy and an average price target of $59.22.

National Health Investors Price Performance

NYSE NHI opened at $62.83 on Monday. The stock has a market capitalization of $2.73 billion, a P/E ratio of 20.07 and a beta of 0.94. National Health Investors has a 1 year low of $47.54 and a 1 year high of $62.93. The business’s fifty day moving average is $56.76 and its two-hundred day moving average is $54.29. The company has a debt-to-equity ratio of 0.90, a quick ratio of 10.27 and a current ratio of 10.27.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Thursday, March 28th will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.73%. The ex-dividend date of this dividend is Wednesday, March 27th. National Health Investors’s payout ratio is 115.02%.

Insider Activity at National Health Investors

In related news, Director Charlotte A. Swafford acquired 10,000 shares of the stock in a transaction on Tuesday, February 27th. The stock was purchased at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the transaction, the director now owns 110,185 shares of the company’s stock, valued at approximately $6,466,757.65. The acquisition was disclosed in a filing with the SEC, which is available through this link. 7.26% of the stock is currently owned by insiders.

Institutional Investors Weigh In On National Health Investors

Institutional investors have recently modified their holdings of the business. Janney Montgomery Scott LLC boosted its stake in National Health Investors by 0.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 23,707 shares of the real estate investment trust’s stock worth $1,324,000 after acquiring an additional 200 shares during the last quarter. Van ECK Associates Corp lifted its position in shares of National Health Investors by 4.3% in the third quarter. Van ECK Associates Corp now owns 4,889 shares of the real estate investment trust’s stock worth $251,000 after purchasing an additional 202 shares in the last quarter. Sound Income Strategies LLC lifted its position in shares of National Health Investors by 33.5% in the fourth quarter. Sound Income Strategies LLC now owns 916 shares of the real estate investment trust’s stock worth $51,000 after purchasing an additional 230 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of National Health Investors by 6.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 3,979 shares of the real estate investment trust’s stock worth $222,000 after purchasing an additional 238 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of National Health Investors by 3.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 7,865 shares of the real estate investment trust’s stock worth $406,000 after purchasing an additional 243 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.